Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05279196
Other study ID # 21_0102
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 2024
Est. completion date March 2028

Study information

Verified date April 2024
Source University Hospital, Montpellier
Contact Stephan MATECKI, MD-PhD
Phone 467335908
Email stephan.matecki@umontpellier.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is in humans, at the muscular level, a great interindividual variability in response to the same mechanical stress. This phenotypic variability is multifactorial, influenced by environmental factors as well as multiple genetic variants. Thus, for the same level of muscle damage, two subjects with the same anthropometric characteristic, the same age, with the same medical history and the same level of physical activity, will present a variable level of muscle regeneration underpinned by the biological function of muscular stem cells and their microenvironment. Thus, faced with the same training, some athletes will develop iterative muscular lesions and more disabling repair deficits than others without knowing the reason of this greater susceptibility. Indeed, the links between the genotype of the skeletal muscle fiber and its response to exercise, as well as the regulation of muscle mass are poorly understood. Yet, in young adults, up to 70% of the observed variability in muscle strength and size is hereditary. This heritability of muscle size and strength seems to be lower in older people, probably related to increased comorbidity. Numerous experiments with athletes subjected to the same resistance exercise training have identified good and bad hypertrophic skeletal muscle responders. However, genetic variants that contribute to skeletal muscle strength and mass are largely understudied while a growing body of evidence indicates that epigenetic effectors, which modulate gene expression, may contribute to human muscle response heterogeneity to the same mechanical stress. Thus, to date, no analysis of the role of the interaction between genetic and epigenetic factors involved in the muscle functional response to exercise exists. The main hypothesis is that the epigenetic status of muscle stem cells (satellite cells) is an important contributor in muscle mass response to exercise by modulating chromatin architecture. Thus this study will identify the epigenetic modifications induced by training and their interaction with the genetic factors involved in the response of the biological function of the satellite cells to this training and on the other hand, to be able to link it to a blood signature.


Description:

The study will be carried out in close collaboration with the Director of the Expertise and Sports Performance Center (CREPS) of Montpellier. Compared to the athlete's usual seasonal training program, his participation in research will be limited to two visits to the Montpellier University Hospital where a quadriceps micro biopsy and a blood test will be carried out. During the first visit to the Montpellier University Hospital, a short clinical examination will also be carried out including an interrogation on his medical history, his consumption of drugs, alcohol, tobacco as well as the measurement of his weight and height and a simple cardiopulmonary auscultation. As part of the standard care for athletes, the training program carried out at CREPS Montpellier will be defined by weekly strength exercises to increase muscle mass. As part of this program and approximately one week before the two visits to the Montpellier University Hospital, an evaluation of the mass and the contractile function of the muscle will be carried out. The measurement of muscle mass will be carried out by Magnetic Resonance Imaging. The contractile function of the quadriceps muscle will be measured on a weight bench equipped with a dynamometer at the CREPS in Montpellier. Data from these assessments will be collected as part of the research. This study will allow the synthesis of a muscular organoid, representative of an in vivo muscle, allowing the in vitro study of muscular lesions associated with the rupture of muscle fibres and the activation of satellite cells allowing the regeneration of damaged fibres. This in vitro muscle model will allow us to evaluate the inter-individual variability of the muscle response to the same mechanical stress and to study its link with the dynamic epigenetic changes specific to each athlete. This study will make it possible, for the first time, to evaluate whether an epigenetic signature predictive of the muscular response to an injury could also be found in blood cells.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date March 2028
Est. primary completion date March 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria: - Senior male athlete aged between 40 and 60 inclusive - Athlete following a program over a season of muscle building at CREPS, the objective of which is to improve their performance in a middle-distance race. Exclusion Criteria: - Subject having a contraindication to follow the complete muscle building program at CREPS with in particular a contraindication to the measurement of muscle mass by Magnetic Resonance Imaging - Subject presenting all criteria which can by themselves alter the function of the respiratory muscles such as chronic obstructive pulmonary disease, heart failure, systemic infection, neuromuscular pathology, psychiatric pathology, metabolic disorder. - Subjects with coagulopathy or thrombocytopenia. - Use of anabolic drugs to increase muscle mass - Subject suspected of doping - Subject allergic to xylocaine

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Quadriceps microbiopsy and blood collection
Microbiopsy of the quadriceps muscle using a needle, "Tru-cut" biopsy, associated with a blood sampling at the start and after 6 months of a muscle strengthening training program

Locations

Country Name City State
France University Hospital Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary DNA methylation profile of satellite cells associated with a gain in muscle mass DNA methylation profile of satellite cells from the quadriceps obtained from athletes at the start and after 6 months of training, will be determine using DNA methylation profiling microarray.
Two groups of athletes will be constituted according to the gain (in % compared to the initial value) in muscular strength of the quadriceps induced by the training and evaluated on a strength bench.
In order to identify a DNA methylation signature associated to the gain in muscle mass, DNA methylation profile will be compared between athletes considered to be good or bad responders to training.
6 months
Secondary Number and size of myoblasts obtained per satellite cells from the quadriceps Satellite cells derived from quadriceps biopsy in athletes at the start and after 6 months of training will be placed in a culture dish treated with type 1 collagen in a thin layer of matrigel. After culture, proliferation and differentiation of myoblast cells will be assessed by cell counting and immunofluorescence with antibodies directed against muscle markers. 6 months
Secondary Comparison of number and size of myoblasts obtained in vitro and the muscular response to training in the same athlete Size of myotubes regenerated in vitro from satellite cells taken from athletes after 6 months of training will be compared to the gain in muscle mass, strength and endurance of the quadriceps induced by training in the same athlete. 6 months
Secondary Comparison of the DNA methylation profile of satellite cells from the quadriceps and blood mononuclear cells in the same athlete DNA methylation profile of satellite cells from the quadriceps and blood mononuclear cells obtained from athletes at the start and after 6 months of training, will be determine using DNA methylation profiling microarray. DNA methylation profile obtained from satellite cells and mononuclear cells in a same athlete will be compared to identify a correlation. 6 months
See also
  Status Clinical Trial Phase
Completed NCT05988476 - Investıgatıon of The Effıciency of Pulsed Electromagnetıc Field Therapy and Stretching Exercises N/A
Active, not recruiting NCT05344183 - Immediate and Short-term Effects of Low-level Laser N/A
Completed NCT05367648 - Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects N/A
Completed NCT05254470 - Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
Completed NCT03676205 - Platelet-Rich Plasma in Acute Muscle Injuries Phase 2
Completed NCT05827484 - The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries Phase 4
Completed NCT04177537 - Real-World Experience of Athletes Treated With SAM
Completed NCT01525667 - Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty Phase 1/Phase 2
Completed NCT04535635 - Effects of ART® on Lower Limb Myofascial Pain and Function N/A
Completed NCT04874662 - Nicotinamide (NAM) and Pyridoxine (Vitamin B6) on Muscle Regeneration ("Satellite-01 Study"). N/A
Completed NCT04742244 - Lemon Verbena Extract Oxidative Stress and Muscle Damage N/A
Active, not recruiting NCT04483986 - Does Rectus Re-approximation Cause Adhesion After Cesarean Section? N/A
Recruiting NCT05216666 - The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty N/A
Completed NCT02077413 - Muscle Injury Prevention & Rehabilitation in Military Personnel N/A
Terminated NCT01751503 - Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer N/A
Withdrawn NCT01497678 - Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center N/A
Completed NCT04586712 - Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury Phase 2
Completed NCT04123782 - Focused Shockwave Treatment in the Recovery Process of Acute Muscle Injuries in Soccer Players N/A
Not yet recruiting NCT01097798 - To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury. Phase 3
Not yet recruiting NCT05285020 - Antigravity Treadmill With Alter G on the Postural Stability of Traumatic Lower Limb Injuries N/A